Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells

被引：0
|
作者：
Claudia Dominici
Nicolas Sgarioto
Zhenbao Yu
Laura Sesma-Sanz
Jean-Yves Masson
Stéphane Richard
Noël J.-M. Raynal
机构：
[1] McGill University,Segal Cancer Center, Lady Davis Institute for Medical Research and Gerald Bronfman Department of Oncology and Departments of Biochemistry, Human Genetics and Medicine
[2] Université de Montréal,Département de Pharmacologie et Physiologie
[3] and Research Centre of the Sainte-Justine University Hospital,Genome Stability Laboratory, CHU de Québec Research Center, Oncology Division, Department of Molecular Biology, Medical Biochemistry and Pathology
[4] Laval University Cancer Research Center,undefined
来源：
Clinical Epigenetics | 2021年 / 13卷
关键词：
Type I PRMT inhibitors; PARP inhibitors; MTAP; Drug resistance; Synergy; Non-small cell lung cancer cells; DNA damage; And cytotoxic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Anticancer effects of tanshinone I in human non-small cell lung cancer
    Lee, Chen-Yu
    Sher, Hui-Fang
    Chen, Huei-Wen
    Liu, Chun-Chi
    Chen, Ching-Hsien
    Lin, Choun-Sea
    Yang, Pan-Chyr
    Tsay, Hsin-Sheng
    Chen, Jeremy J. W.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (11) : 3527 - 3538
  • [42] Identification of resistance mechanisms to EGFR inhibitors in non-small cell lung cancer cells
    de Bruin, E. C.
    Cowell, C. F.
    Howell, M.
    Downward, J.
    EJC SUPPLEMENTS, 2010, 8 (05): : 57 - 58
  • [43] Primary and Acquired Resistance against Immune Check Inhibitors in Non-Small Cell Lung Cancer
    Sun, Qinying
    Wei, Xiangzhen
    Wang, Zhonglin
    Zhu, Yan
    Zhao, Weiying
    Dong, Yuchao
    CANCERS, 2022, 14 (14)
  • [44] Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
    Li, Hecheng
    Zhu, XiaoLi
    Zhang, Yawei
    Xiang, Jiaqing
    Chen, Haiquan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [45] Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
    Iglesias, Venus Sosa
    Theys, Jan
    Groot, Arjan J.
    Barbeau, Lydie M. O.
    Lemmens, Alyssa
    Yaromina, Ala
    Losen, Mario
    Houben, Ruud
    Dubois, Ludwig
    Vooijs, Marc
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [46] Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction
    Hecheng Li
    XiaoLi Zhu
    Yawei Zhang
    Jiaqing Xiang
    Haiquan Chen
    Journal of Experimental & Clinical Cancer Research, 28
  • [47] The synergistic effects between gefitinib and anti-microtubule agents in non-small cell lung cancer cells and patients
    Tsai Chun-Ming
    Chang Kuo-Ting
    Chiu Chao-hua
    Chen Tina
    Hsiao Shih-Yin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S555 - S555
  • [48] The Genomic Scarring Score as a Biomarker for the Use of PARP Inhibitors in Early-Stage Non-Small Cell Lung Cancer
    Tsilingiri, K.
    Chalari, A.
    Christopoulou, G.
    Voutsina, A.
    Vatsellas, I.
    Loupis, T.
    Vrachnos, D.
    Potaris, K.
    Vamvakaris, I.
    Zachou, G.
    Georgoulias, V.
    Constantoulakis, P.
    Kotsakis, A.
    Klinakis, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S447 - S447
  • [49] A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer
    Park, Sang Hyuk
    Chi, Hyun-Sook
    Kim, Young Jin
    Cho, Young-Uk
    Jang, Seongsoo
    Park, Chan-Jeoung
    Kim, Sang-We
    ANNALS OF LABORATORY MEDICINE, 2014, 34 (02) : 163 - 165
  • [50] Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
    Jie, Chen
    Li, Rumeng
    Cheng, Yajie
    Wang, Zhihao
    Wu, Qiuji
    Xie, Conghua
    FRONTIERS IN IMMUNOLOGY, 2023, 14
12345